9 results on '"Biggeri, A"'
Search Results
2. Low Incidence of End-Stage Renal Disease and Chronic Renal Failure in Type 2 Diabetes: A 10-year prospective study
- Author
-
Bruno, Graziella, Biggeri, Annibale, Merletti, Franco, Bargero, Giuseppe, Ferrero, Stefania, Pagano, Gianfranco, and Perin, Paolo Cavallo
- Published
- 2003
3. Progression to Overt Nephropathy in Type 2 Diabetes: The Casale Monferrato Study
- Author
-
Bruno, Graziella, Merletti, Franco, Biggeri, Annibale, Bargero, Giuseppe, Ferrero, Stefania, Pagano, Gianfranco, and Perin, Paolo Cavallo
- Published
- 2003
4. Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes
- Author
-
Paolo Cavallo-Perin, Giuseppe Bargero, Annibale Biggeri, Franco Merletti, Gianfranco Pagano, Cristina Runzo, Stefano Prina Cerai, Graziella Bruno, and Stefania Ferrero
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,education.field_of_study ,Proportional hazards model ,business.industry ,Endocrinology, Diabetes and Metabolism ,Hazard ratio ,Population ,Type 2 diabetes ,medicine.disease ,Endocrinology ,Diabetes mellitus ,Internal medicine ,Cohort ,Internal Medicine ,medicine ,Metabolic syndrome ,education ,business ,Cohort study - Abstract
OBJECTIVE—The aim of this study was to assess in an 11-year survival follow-up of a population-based cohort of type 2 diabetes the predictive role of World Health Organization–defined metabolic syndrome, independent of conventional cardiovascular risk factors. RESEARCH DESIGN AND METHODS—During the follow-up (1991–2001), 1,565 patients were regularly examined with centralized measurements of HbA1c. The independent role of the metabolic syndrome as a predictor of all-cause and cardiovascular mortality was assessed with multivariate Cox proportional hazards modeling. RESULTS—At baseline, the prevalence of the metabolic syndrome was 75.6% (95% CI 73.6–77.9). Results are based on 685 deaths (520 with the metabolic syndrome and 165 without it) in 10,890.2 person-years of observations. With respect to subjects without the metabolic syndrome, those with the metabolic syndrome had a similar hazard ratio (HR) of cardiovascular mortality after adjustment for age, sex, smoking, total cholesterol level, and coronary heart disease. In contrast, relative to subjects with diabetes only, the HR of subjects with only one component of the syndrome was 2.92 (1.16–7.33), independent of other risk factors. CONCLUSIONS—We found that 1) the prevalence of the metabolic syndrome in a population-based cohort of type 2 diabetes is high (75.6%); 2) the metabolic syndrome is not a predictor of 11-year all-cause and cardiovascular mortality; and 3) more than twofold higher cardiovascular risk, independent of conventional risk factors, is evident in diabetic subjects with only one component of the syndrome compared with those with diabetes only. Categorizing type 2 diabetic subjects as having or not having the metabolic syndrome does not provide further prediction compared with the knowledge of its single components.
- Published
- 2004
5. Low Incidence of End-Stage Renal Disease and Chronic Renal Failure in Type 2 Diabetes
- Author
-
Stefania Ferrero, Graziella Bruno, Franco Merletti, Giuseppe Bargero, Gianfranco Pagano, Paolo Cavallo Perin, and Annibale Biggeri
- Subjects
Advanced and Specialized Nursing ,education.field_of_study ,medicine.medical_specialty ,Creatinine ,business.industry ,Proportional hazards model ,Endocrinology, Diabetes and Metabolism ,Population ,Type 2 diabetes ,medicine.disease ,Surgery ,End stage renal disease ,chemistry.chemical_compound ,chemistry ,Internal medicine ,Diabetes mellitus ,Internal Medicine ,medicine ,education ,business ,Prospective cohort study ,Kidney disease - Abstract
OBJECTIVE—Data on the incidence of end-stage renal disease (ESRD) and chronic renal failure from population-based studies in Caucasian type 2 diabetic patients are lacking. To provide such data, a population-based cohort of type 2 diabetic patients was identified in Casale Monferrato, Italy, and prospectively examined from 1991 to 2001. RESEARCH DESIGN AND METHODS—During the follow-up period, patients were regularly examined with centralized measurements of plasma creatinine and HbA1c. Independent predictors of progression to renal events were identified with multivariate Cox proportional hazards modeling, with sex, age, and individual follow-up time as confounders. RESULTS—We followed 1,408 of 1,540 (91.4%) patients (average follow-up time 6.7 years, range 0.011–11.1); 10 new cases of ESRD and 72 of chronic renal failure (plasma values of creatinine ≥2.0 mg/dl) were identified, giving incidence rates/1,000 person-years of 1.04 (95% CI 0.56–1.94) and 7.63 (6.06–9.61), respectively. Cumulative risks for chronic renal failure adjusted for competing mortality were 6.1 and 9.3% after 20 and 30 years from diagnosis of diabetes, respectively. Incidence rates and cumulative risks of chronic renal failure defined by plasma creatinine values >1.5 mg/dl increased to 13.1/1,000 person-years, 8.6 and 14.8%, respectively. In Cox regression analysis, predictors of progression (after adjustment for confounders) were hypertension (P = 0.078), diastolic blood pressure (P = 0.034), BMI (P = 0.03), and albumin excretion rate (AER) (P < 0.0001). CONCLUSIONS—We provide evidence that the individual risk of ESRD and chronic renal failure is low. AER and diastolic blood pressure are independent predictors of progression. These findings underline the relevance of primary prevention to reduce the number of diabetic patients with ESRD.
- Published
- 2003
6. Progression to Overt Nephropathy in Type 2 Diabetes
- Author
-
Giuseppe Bargero, Stefania Ferrero, Gianfranco Pagano, Paolo Cavallo Perin, Annibale Biggeri, Graziella Bruno, and Franco Merletti
- Subjects
Advanced and Specialized Nursing ,education.field_of_study ,medicine.medical_specialty ,business.industry ,Endocrinology, Diabetes and Metabolism ,Population ,Type 2 diabetes ,medicine.disease ,Gastroenterology ,Nephropathy ,Diabetic nephropathy ,Blood pressure ,Endocrinology ,Diabetes mellitus ,Internal medicine ,Internal Medicine ,Medicine ,Microalbuminuria ,business ,education ,Kidney disease - Abstract
OBJECTIVE—The first sign of diabetic nephropathy is microalbuminuria, but its predictive role of progression to overt nephropathy in type 2 diabetes has not yet been clarified. The aims of this study were to assess during 7 years of follow-up the incidence rate of overt nephropathy and the predictive role of microalbuminuria and other baseline variables (blood pressure, lipids, fibrinogen, uric acid, smoking, and HbA1c cumulative average during follow-up). RESEARCH DESIGN AND METHODS—A prospective population-based study was performed in Casale Monferrato, Italy, including 1,253 type 2 diabetic patients recruited at baseline (1991–1992), 765 with normoalbuminuria (albumin excretion rate [AER] RESULTS—Of 1,253 total patients, 1,103 (88.0%) were included in the follow-up examination (median 5.33 years); their age and duration of disease at baseline were 68.4 ± 10.5 years and 10.4 ± 6.6 years, respectively. Cases of overt nephropathy were 202, giving an incidence rate of 37.0/1,000 person-years (95% CI 32.3–42.6). In conditional logistic regression analyses, microalbuminuria provided a 42% increased risk with respect to normoalbuminuria (95% CI 0.98–2.06), independently of duration of diabetes, hypertension, and systolic blood pressure. Other variables independently associated with progression to overt nephropathy were HbA1c cumulative average (P = 0.002), apolipoprotein B (P = 0.013), fibrinogen (P = 0.02), and HDL cholesterol (P = 0.03). CONCLUSIONS—Of type 2 diabetic patients, 3.7% progress every year to overt nephropathy. Microalbuminuria is associated with a 42% increased risk of progression to overt nephropathy. Other independent predictors are HbA1c, HDL cholesterol, apolipoprotein B, and fibrinogen.
- Published
- 2003
7. National Diabetes Programs: Application of capture-recapture to count diabetes?
- Author
-
Bruno, Graziella, primary, Laporte, Ronald E, additional, Merletti, Franco, additional, Biggeri, Annibale, additional, McCarty, Daniel, additional, and Pagano, Gianfranco, additional
- Published
- 1994
- Full Text
- View/download PDF
8. Metabolic Syndrome as a Predictor of All-Cause andCardiovascular Mortality in Type 2 Diabetes.
- Author
-
Bruno, Graziella, Merletti, Franco, Biggeri, Annibale, Bargero, Giuseppe, Ferrero, Stefania, Runzo, Cristina, Cerai, Stefano Prina, Pagano, Gianfranco, and Cavallo-Perin, Paolo
- Subjects
TYPE 2 diabetes ,CARDIOVASCULAR diseases ,DISEASE risk factors ,CHOLESTEROL ,DIABETES - Abstract
OBJECTIVE -- The aim of this study was to assess in an 11-year survival follow-up of a population-based cohort of type 2 diabetes the predictive role of World Health Organization-defined metabolic syndrome, independent of conventional cardiovascular risk factors. RESEARCH DESIGN AND METHODS -- During the follow-up (1991-2001), 1,565 patients were regularly examined with centralized measurements of HbA[sub1c]. The independent role of the metabolic syndrome as a predictor of all-cause and cardiovascular mortality was assessed with multivariate Cox proportional hazards modeling. RESULTS -- At baseline, the prevalence of the metabolic syndrome was 75.6% (95% CI 73.6-77.9). Results are based on 685 deaths (520 with the metabolic syndrome and 165 without it) in 10,890.2 person-years of observations. With respect to subjects without the metabolic syndrome, those with the metabolic syndrome had a similar hazard ratio (HR) of cardiovascular mortality after adjustment for age, sex, smoking, total cholesterol level, and coronary heart disease. In contrast, relative to subjects with diabetes only, the HR of subjects with only one component of the syndrome was 2.92 (1.16-7.33), independent of other risk factors. CONCLUSIONS -- We found that 1) the prevalence of the metabolic syndrome in a population-based cohort of type 2 diabetes is high (75.6%); 2) the metabolic syndrome is not a predictor of 11-year all-cause and cardiovascular mortality; and 3) more than twofold higher cardiovascular risk, independent of conventional risk factors, is evident in diabetic subjects with only one component of the syndrome compared with those with diabetes only. Categorizing type 2 diabetic subjects as having or not having the metabolic syndrome does not provide further prediction compared with the knowledge of its single components. [ABSTRACT FROM AUTHOR]
- Published
- 2004
- Full Text
- View/download PDF
9. National Diabetes Programs.
- Author
-
Bruno, Graziella, LaPorte, Ronald E., Merletti, Franco, Biggeri, Annibale, McCarty, Daniel, and Pagano, Gianfranco
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.